SCHEMBL14939619

SCHEMBL14939619

Cc1ccc2c(c1)CC(c1cccc(F)c1)C2=O

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.52
SLC6A4 P31645 2/20 0.52
SLC6A3 Q01959 2/20 0.52
CYP19A1 P11511 4/20 0.48
METAP1 P53582 1/20 0.44
MAOB P27338 4/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HTR2A P28223 4/20 0.40
HTR2C P28335 4/20 0.40
HTR2B P41595 4/20 0.40
HRH3 Q9Y5N1 4/20 0.40
ALOX15 P16050 1/20 0.40
ALOX12 P18054 1/20 0.40
PKM P14618 1/20 0.40
ACHE P22303 1/20 0.40
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14939388 0.89 CYP19A1 (0.48) SLC6A2SLC6A4SLC6A3CYP19A1METAP1
SCHEMBL14938930 0.88 CYP19A1 (0.52) CYP19A1MAOBL3MBTL1HTR2AHTR2C
SCHEMBL14939596 0.84 CYP19A1 (0.60) SLC6A2SLC6A4SLC6A3CYP19A1METAP1
SCHEMBL14939233 0.81 METAP1 (0.45) SLC6A2SLC6A4SLC6A3CYP19A1METAP1
SCHEMBL14940109 0.78 CYP19A1 (0.55) SLC6A2SLC6A4SLC6A3CYP19A1MAOB
SCHEMBL14939569 0.77 HTR2A (0.41) SLC6A2SLC6A4SLC6A3CYP19A1MAOB
SCHEMBL10649546 0.77 CYP19A1 (0.47) CYP19A1METAP1L3MBTL1ALOX15KDM4E
SCHEMBL14939220 0.77 CYP19A1 (0.59) CYP19A1METAP1L3MBTL1ALOX15ALOX12
SCHEMBL28815103 0.75 CYP19A1 (0.48) CYP19A1MAOBL3MBTL1HTR2AHTR2C
SCHEMBL7836162 0.74 NOS3 (0.49) SLC6A4CYP19A1MAOBHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013068785-A1 INDANONE AND INDANDIONE DERIVATIVES AND HETEROCYCLIC ANALOGS ACTELION PHARMACEUTICALS LTD (CH) 2013-05-16 WO disclosed